Jingrong Jean Cui, Director at Turning Point Therapeutics, Inc. (TPTX), sold 109,670 shares at $53.05 ($5.8M) on 2020-05-05, disclosed to the SEC on 2020-05-07.
Open-market sale of $5.8M TPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.05 | 3,998 | $212K | 3.6% |
| 2 | $53.05 | 3,998 | $212K | 3.6% |
| 3 | $54.04 | 8,718 | $471K | 8.1% |
| 4 | $54.04 | 8,718 | $471K | 8.1% |
| 5 | $54.67 | 5,784 | $316K | 5.4% |
| 6 | $54.67 | 5,784 |
| $316K |
| 5.4% |
| 7 | $52.54 | 6,072 | $319K | 5.5% |
| 8 | $52.54 | 6,072 | $319K | 5.5% |
| 9 | $53.13 | 12,428 | $660K | 11.3% |
| 10 | $53.13 | 12,428 | $660K | 11.3% |
| 11 | $52.22 | 5,306 | $277K | 4.7% |
| 12 | $52.22 | 5,306 | $277K | 4.7% |
| 13 | $53.05 | 11,864 | $629K | 10.8% |
| 14 | $53.05 | 11,864 | $629K | 10.8% |
| 15 | $53.70 | 1,330 | $71K | 1.2% |
| Total | $53.27 avg | 109,670 | $5.8M | 100% |
| Filing → |
| TPTX | SELL | 2020-05-21 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-12 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-04-24 | $1.5M | — | Filing → |